在患有恶性瘤的患者中与中性热肠炎相关的抗质药物:定量安全信号分析
Ali Amanati1,2, Robbert Van Manen3, Sarvin Sajedianfard1
1Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
概括
化学疗法相关的中性无肠炎 (CANE) 风险在抗瘤药物之间有所不同. 这项研究确定了22种与CANE密切相关的药物,突出了药监数据的知识差距.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 胃肠病学 胃肠病学
背景情况:
- 某些化疗剂可能会导致化疗相关的中性衰竭肠球炎 (CANE).
- 了解每种抗瘤剂的特定风险对于患者的安全至关重要.
研究的目的:
- 评估与单个抗瘤剂相关的CANE发展风险.
- 确定与CANE有显著关联的抗瘤药物.
主要方法:
- 使用了FDA不良事件报告系统 (FAERS) 数据库.
- 搜索了"中性衰竭性结肠炎"作为首选术语.
- 分析报告的几率比率 (ROR),以确定药物事件的关联.
主要成果:
- 在接受化疗的患者中鉴定了1134例中性衰竭性结肠炎.
- 发现22种与CANE有很强的关联 (ROR>100) 的抗瘤药物.
- 观察到9种药物具有较低的ROR (< 2),表明相关性较弱.
结论:
- 药物数据库在反映新发现的不良事件方面存在局限性.
- 信号检测在药监中,使用像FDA FAERS这样的数据库,是识别不良药物事件的实用方法.
- 在CANE和FDA报告新产品时,已知抗瘤剂的风险之间存在很大的差距.
更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
12.4K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
162
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
162
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200